Observational study of the profile of patients undergoing hip and knee arthroplasty in Chilean public hospitals funded through Diagnosis-Related Groups, from 2019 to 2023
Medwave · 2025
DOI: 10.5867/medwave.2025.08.3111 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medwave, 2025. Verfasst von Maximiliano Barahona und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ortopedia y Traumatología, Hospital Clínico Universidad de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Diagnosis-Related Groups, Osteoarthritis, Knee. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Hip and knee osteoarthritis are common causes of disability, with high social and economic impact. Total hip and knee arthroplasties are cost-effective interventions that significantly improve quality of life. However, timely access to these surgeries in the Chilean public healthcare system remains limited. Since 2019, the Diagnosis-Related Groups (DRG) system has enabled the financing of hospital surgical procedures by adjusting payments according to case complexity. The objective of our study was to describe the hospital volume, clinical profile of patients, and financing situation of arthroplasties performed between 2019 and 2023 in public hospitals operating under the Diagnosis-Related Groups system.
Methods
Observational, cross-sectional, and retrospective study. All procedures coded as primary total hip arthroplasty or total knee arthroplasty recorded in the Diagnosis-Related Groups database of the National Health Fund (FONASA) between January 2019 and September 2023 were analyzed. Clinical, demographic, geographic, and economic variables were extracted. Comorbidities were identified using the International Classification of Diseases, 10th revision (ICD-10)
Results
A total of 29 409 primary and 1993 revision arthroplasties were performed. Surgical volume decreased in 2020 and recovered progressively. Hospital productivity varied across regions. One-third of the total hip arthroplasties were performed in patients under 65 years old. The most frequent comorbidities were hypertension (43.4%) and diabetes (16.6%). The average reimbursement for revision surgeries was similar to that of primary procedures.
Conclusions
We identified regional inequities in access to total hip and knee replacements. We also found possible underreporting of comorbidities and underfunding of revisions, which highlights the need for specific adjustments to the Diagnosis-Related Groups system. In the future, it will be necessary to improve the quality of coding, expand financial coverage for patients excluded from the Explicit Health Guarantees, and incorporate technological adjustments that adequately reflect the costs of revisions, to move toward equitable and sustainable access to these surgeries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Ortopedia y Traumatología, Hospital Clínico Universidad de Chile, Santiago, Chile.
ORCID-Profile: Maximiliano Barahona, Macarena Barahona, Joaquin Domínguez, Luis Beltran, Alvaro Martinez
Zitieren
APA
Barahona, M., Barahona, M., Domínguez, J., Beltran, L., & Martinez, A. (2025). Observational study of the profile of patients undergoing hip and knee arthroplasty in Chilean public hospitals funded through Diagnosis-Related Groups, from 2019 to 2023. Medwave. https://doi.org/10.5867/medwave.2025.08.3111
Vancouver
Barahona M, Barahona M, Domínguez J, Beltran L, Martinez A. Observational study of the profile of patients undergoing hip and knee arthroplasty in Chilean public hospitals funded through Diagnosis-Related Groups, from 2019 to 2023. Medwave. 2025. doi:10.5867/medwave.2025.08.3111
BibTeX
@article{Barahona2025,
author = {Barahona, Maximiliano and Barahona, Macarena and Domínguez, Joaquin and Beltran, Luis and Martinez, Alvaro},
title = {Observational study of the profile of patients undergoing hip and knee arthroplasty in Chilean public hospitals funded through Diagnosis-Related Groups, from 2019 to 2023},
journal = {Medwave},
year = {2025},
doi = {10.5867/medwave.2025.08.3111}
}
EUVIMED